Title of article
Autophagy Suppresses Tumorigenesis through Elimination of p62
Author/Authors
Robin Mathew، نويسنده , , Cristina M. Karp، نويسنده , , Brian Beaudoin، نويسنده , , Nhan Vuong، نويسنده , , Guanghua Chen، نويسنده , , Hsin-Yi Chen، نويسنده , , Kevin Bray، نويسنده , , Anupama Reddy، نويسنده , , Gyan Bhanot، نويسنده , , Celine Gelinas، نويسنده , , Robert S. DiPaola، نويسنده , , Vassiliki Karantza-Wadsworth، نويسنده , , Eileen White، نويسنده ,
Issue Information
هفته نامه با شماره پیاپی سال 2009
Pages
14
From page
1062
To page
1075
Abstract
Allelic loss of the essential autophagy gene beclin1 occurs in human cancers and renders mice tumor-prone suggesting that autophagy is a tumor-suppression mechanism. While tumor cells utilize autophagy to survive metabolic stress, autophagy also mitigates the resulting cellular damage that may limit tumorigenesis. In response to stress, autophagy-defective tumor cells preferentially accumulated p62/SQSTM1 (p62), endoplasmic reticulum (ER) chaperones, damaged mitochondria, reactive oxygen species (ROS), and genome damage. Moreover, suppressing ROS or p62 accumulation prevented damage resulting from autophagy defects indicating that failure to regulate p62 caused oxidative stress. Importantly, sustained p62 expression resulting from autophagy defects was sufficient to alter NF-κB regulation and gene expression and to promote tumorigenesis. Thus, defective autophagy is a mechanism for p62 upregulation commonly observed in human tumors that contributes directly to tumorigenesis likely by perturbing the signal transduction adaptor function of p62-controlling pathways critical for oncogenesis.
Journal title
CELL
Serial Year
2009
Journal title
CELL
Record number
1019790
Link To Document